AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 8-K$GRDN

Guardian Pharmacy Services Reports Third Quarter 2026 Financial Results; Raises Full-Year Guidance

Guardian Pharmacy Services, Inc. (GRDN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Guardian Pharmacy Services Reports Third Quarter 2026 Financial Results; Raises Full-Year Guidance ATLANTA, November 5, 2026 – Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financ

Original reporting
SEC EDGAR 8-K
Published Nov 5, 2026, 9:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 9:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$GRDN
Bullish
high confidence
Mentioned
$GRDN
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$GRDNBullishMed
01

Why it matters

The raised guidance reflects stronger resident growth and margin improvement, likely prompting a short‑term price rally.

02

Market read

Earnings beat and raised guidance provide a fresh catalyst for GRDN, supporting a bullish short‑term outlook.

03

What to watch

Integration risks from recent acquisitions could delay margin expansion.

Relevance 7/10Novelty 8/10Timing: after-hours today

Background

Guardian Pharmacy Services, a NYSE‑listed long‑term care pharmacy provider, filed an 8‑K reporting Q3 2026 results and raised its FY guidance.

Company-level read

Ticker impact

$GRDNBullishHigh confidence
Context

Guardian Pharmacy Services raised its full-year revenue and EBITDA guidance in its Q3 2026 earnings release.

Expected impact

likely upward pressure as the market prices in raised full-year guidance

Evidence & confidence

The company reported higher resident growth and improved margins, and explicitly raised its FY revenue to $1.44‑$1.46 B and adjusted EBITDA to $136‑$138 M, which should support a price rally.

Market effects

Sector

Positive for the long‑term care pharmacy sector as the guidance raise suggests demand growth.

Regional

May boost investor sentiment toward U.S. healthcare stocks.

Global

Limited to U.S. healthcare investors.

Counterpoint

What could challenge this read

If pricing pressure from the IRA persists, revenue growth could stall, tempering upside.

Key entities

  • company
    Guardian Pharmacy Services

    NYSE‑listed long‑term care pharmacy services provider.

Read at source← All news

Related articles

$GRDNMedAI 8/10

Guardian Pharmacy Services (GRDN) Q2 2026 Earnings Call Transcript

Guardian Pharmacy Services (GRDN) reported Q2 2026 revenue of $351.8 million, up 2% year over year, and adjusted EBITDA of $29.7 million, up 19%. Net income rose to $22.1 million. The company raised full-year 2026 guidance to $1.43 billion to $1.45 billion revenue and $129 million to $131 million adjusted EBITDA, citing underlying growth despite IRA pricing pressure.

fool.com
$GRDNMed

Guardian Pharmacy Services Q2 Earnings Call Highlights

Guardian Pharmacy Services (GRDN) reported Q2 net income of $22.1M vs $8.8M a year earlier, including an $8.5M payer-dispute settlement recorded as other income. The company expects H2 revenue to fall low-single digits YoY due to IRA pricing reductions, with adjusted EBITDA margin stable in Q3 and seasonally higher in Q4. It also appointed Morris as COO and named a new CFO.

yahoo.com
$GRDNMedAI 8/10

Guardian Pharmacy: Q2 Earnings Snapshot

Guardian Pharmacy Services Inc. (GRDN) reported Q2 profit of $21.9 million, or 34 cents per share. Adjusted earnings were 29 cents versus a Zacks-surveyed analyst average of 26 cents. Revenue was $351.8 million. The company forecast full-year revenue of $1.43 billion to $1.45 billion.

local3news.com
$GRDNHigh

Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance

Guardian Pharmacy Services, Inc. (GRDN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance ATLANTA, August 6, 2026 – Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation’s leading long-term care (“LTC”) pharmacy services companies, announced toda

SEC EDGAR 8-K